Familial hypercholesterolemia: current status of the problem, treatment, and prevention-Reference-Cited by-同舟云学术

Familial hypercholesterolemia: current status of the problem, treatment, and prevention

Published:2020-11-14 Issue:5 Volume:19 Page:2532
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Bliznyuk S. A.¹^ORCID,Bubnova M. G.¹^ORCID,Ezhov M. V.²^ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

2. National Medical Research Center of Cardiology

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478-90. doi:10.1093/eurheartj/eht273.

2. Akioyamen LE, Genest J, Shan SD, et al. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;9(7):e016461. doi:10.1136/bmjopen-2017-016461.

3. Ershova AI, Meshkov AN, Bazhan SS, et al. The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF. 2017;12(7):e0181148. doi:10.1371/journal.pone.0181148.

4. Nordestgaard BG, Benn M. Genetic testing for familial hyper-cholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world? Eur Heart J. 2017;38(20):1580-3. doi:10.1093/eurheartj/ehx136.

5. Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974;249(16):5153-62.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the global and national market for lipid modifying agents: retrospective and innovation;Сибирский научный медицинский журнал;2023-08-29

2. Hypercholesterolemia at a young age;Ateroscleroz;2021-08-10